题名 | Optimal strength and timing of steroids in the management of erlotinib-related skin toxicities in a post-marketing surveillance study (POLARSTAR) of 9909 non-small-cell lung cancer patients. |
链接 | http://link.springer.com/article/10.1007%2Fs10147-015-0893-5 |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |